A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis

Clinical trial NCT02546323 · COMPLETED

Trial details

NCT number: NCT02546323
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2015-09-17
Primary completion: 2019-01-29
Enrollment: 543

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.